Teleflex Incorporated (NYSE:TFX – Get Free Report) saw a large growth in short interest during the month of March. As of March 15th, there was short interest totalling 2,420,000 shares, a growth of 116.1% from the February 28th total of 1,120,000 shares. Approximately 5.2% of the shares of the company are short sold. Based on an average daily trading volume, of 998,200 shares, the days-to-cover ratio is presently 2.4 days.
Analyst Upgrades and Downgrades
Several analysts have recently commented on the stock. Citizens Jmp downgraded shares of Teleflex from an “outperform” rating to a “market perform” rating in a report on Thursday, February 27th. Morgan Stanley lowered their price target on shares of Teleflex from $275.00 to $191.00 and set an “overweight” rating on the stock in a report on Wednesday, March 5th. Piper Sandler reiterated a “neutral” rating and set a $140.00 price objective (down previously from $255.00) on shares of Teleflex in a research note on Friday, February 28th. StockNews.com downgraded Teleflex from a “buy” rating to a “hold” rating in a research note on Friday, February 28th. Finally, Truist Financial reduced their price target on Teleflex from $200.00 to $149.00 and set a “hold” rating for the company in a research report on Monday, March 3rd. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $182.63.
Check Out Our Latest Analysis on Teleflex
Institutional Inflows and Outflows
Teleflex Stock Performance
Shares of TFX stock opened at $137.76 on Friday. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. Teleflex has a 12-month low of $128.55 and a 12-month high of $249.91. The business’s 50 day moving average is $159.20 and its two-hundred day moving average is $190.36. The company has a market capitalization of $6.39 billion, a P/E ratio of 27.39, a P/E/G ratio of 1.73 and a beta of 1.21.
Teleflex (NYSE:TFX – Get Free Report) last announced its earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.86 by $0.03. The firm had revenue of $795.40 million for the quarter, compared to analyst estimates of $813.24 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. Analysts expect that Teleflex will post 13.98 EPS for the current fiscal year.
Teleflex Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Monday, March 17th. Stockholders of record on Friday, March 7th were paid a dividend of $0.34 per share. The ex-dividend date was Friday, March 7th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.99%. Teleflex’s dividend payout ratio is currently 95.77%.
About Teleflex
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.
Featured Stories
- Five stocks we like better than Teleflex
- The 3 Best Retail Stocks to Shop for in August
- Venezuelan Tariffs Could Power These 3 Diesel-Driven Winners
- The Most Important Warren Buffett Stock for Investors: His Own
- MarketBeat Week in Review – 03/24 – 03/28
- How to Invest in the Best Canadian Stocks
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.